Corline Biomedical
17.40 SEK
-1.97 %
Less than 1K followers
CLBIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-1.97 %
-10.54 %
+16.78 %
+79.38 %
+98.18 %
+135.77 %
+82.77 %
+24.26 %
+75.91 %
Corline Biomedical is active in the pharmaceutical industry. The company works with the substance heparin and has developed a portfolio of drug candidates for use in connection with organ and cell transplantation. The company sells its proprietary product CHS™ to medical technology customers, and is developing Renaparin® for use in regenerative medicine and organ transplantation. The headquarters are located in Uppsala.
Read moreMarket cap
445.68M SEK
Turnover
162.09K SEK
Revenue
9.78M
EBIT %
-236.91 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
17.2
2026
Annual report '25
8.5
2026
Interim report Q1'26
26.8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Redeye: Corline Biomedical - Kardium receives FDA approval
Redeye: Corline Biomedical Q2 - Kardium’s Globe system nearing launch
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools